Literature DB >> 20712422

Vascular wall as a reservoir for different types of stem and progenitor cells.

Süleyman Ergün1, Derya Tilki, Diana Klein.   

Abstract

Tissue regeneration and several diseases such as tumor and atherosclerosis depend on new vessel formation by both angiogenesis and vasculogenesis. Endothelial cells (ECs) are widely considered to be the active cellular component in these processes, followed by contractile cells such as pericytes and smooth muscle cells. The best known sources providing these cell types or their progenitors are ECs lining the vessel lumen and bone marrow. As easily evident, the vessel wall was recognized as being a passive player to a great extent except ECs of the vascular intima. Particularly, the vascular adventitia has been considered as a passive layer rather than an active part of the vessel wall. But results provided during the last few years have led to a revision of this classical view because of an apparent stem cell niche function of the vascular adventitia. This review aims to sum up findings identifying the vessel wall as an important stem cell reservoir and discusses its impact on health and disease.

Entities:  

Mesh:

Year:  2011        PMID: 20712422     DOI: 10.1089/ars.2010.3507

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  38 in total

Review 1.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

Review 2.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

3.  Endothelial progenitor cells=EPC=elemental pernicious complexity.

Authors:  Ralf P Brandes; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

4.  Aneurysm Development in Patients With Bicuspid Aortic Valve (BAV): Possible Connection to Repair Deficiency?

Authors:  Shohreh Maleki; Hanna M Björck; Valentina Paloschi; Sanela Kjellqvist; Lasse Folkersen; Veronica Jackson; Anders Franco-Cereceda; Per Eriksson
Journal:  Aorta (Stamford)       Date:  2013-06-01

5.  Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter.

Authors:  Takakuni Maki; Mitsuyo Maeda; Maiko Uemura; Evan K Lo; Yasukazu Terasaki; Anna C Liang; Akihiro Shindo; Yoon Kyung Choi; Akihiko Taguchi; Tomohiro Matsuyama; Ryosuke Takahashi; Masafumi Ihara; Ken Arai
Journal:  Neurosci Lett       Date:  2015-04-30       Impact factor: 3.046

Review 6.  Defining vascular stem cells.

Authors:  Ching-Shwun Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2013-01-18       Impact factor: 3.272

7.  Role of pericytes in skeletal muscle regeneration and fat accumulation.

Authors:  Alexander Birbrair; Tan Zhang; Zhong-Min Wang; Maria Laura Messi; Grigori N Enikolopov; Akiva Mintz; Osvaldo Delbono
Journal:  Stem Cells Dev       Date:  2013-04-27       Impact factor: 3.272

Review 8.  Brain mesenchymal stem cells: The other stem cells of the brain?

Authors:  Florence Appaix; Marie-France Nissou; Boudewijn van der Sanden; Matthieu Dreyfus; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

9.  Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.

Authors:  Diana Klein; Jennifer Steens; Alina Wiesemann; Florian Schulz; Farnusch Kaschani; Katharina Röck; Masahiro Yamaguchi; Florian Wirsdörfer; Markus Kaiser; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  Antioxid Redox Signal       Date:  2016-11-14       Impact factor: 8.401

Review 10.  Is CD34 truly a negative marker for mesenchymal stromal cells?

Authors:  Ching-Shwun Lin; Hongxiu Ning; Guiting Lin; Tom F Lue
Journal:  Cytotherapy       Date:  2012-11       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.